Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Newly Diagnosed Acute Myeloid Leukemia (AML)”

361 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 361 results

Post-approval studies (Phase 4)Active Not RecruitingNCT05144243
What this trial is testing

Study to Assess Adverse Events and Change in Disease State of Oral Venetoclax in Combination With Subcutaneous (SC) Azacitidine in Newly Diagnosed Adult Participants With Acute Myeloid Leukemia (AML) Who Are Ineligible for Intensive Chemotherapy in China

Who this might be right for
Acute Myeloid Leukemia (AML)
AbbVie 44
Testing effectiveness (Phase 2)Study completedNCT00129168
What this trial is testing

Zosuquidar in Combination With Daunorubicin and Cytarabine in Patients Ages 55-75 With Newly Diagnosed Acute Myeloid Leukemia (AML)

Who this might be right for
Leukemia, Myeloid
Kanisa Pharmaceuticals 100
Testing effectiveness (Phase 2)WithdrawnNCT03760445
What this trial is testing

HDM201 Added to CT in R/R or Newly Diagnosed AML

Who this might be right for
Leukemia, Myeloid, Acute
Novartis Pharmaceuticals
Early research (Phase 1)Ended earlyNCT02319369
What this trial is testing

Safety, Tolerability and Pharmacokinetics of Milademetan Alone and With 5-Azacitidine (AZA) in Acute Myelogenous Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)

Who this might be right for
Acute Myelogenous LeukemiaMyelodysplastic Syndrome
Daiichi Sankyo 74
Early research (Phase 1)Study completedNCT00990054
What this trial is testing

Study of Plerixafor Combined With Cytarabine and Daunorubicin in Patients With Newly Diagnosed Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
Genzyme, a Sanofi Company 36
Large-scale testing (Phase 3)Study completedNCT03379727
What this trial is testing

Study to Assess the Safety and Efficacy of Midostaurin (PKC412) in Combination With Standard Chemotherapy During Induction and Consolidation Followed by 12 Months of Maintenance Monotherapy in Patients With Newly-diagnosed FMS-like Tyrosine 3 (FLT3) Kinase Receptor-mutated Acute Myeloid Leukemia.

Who this might be right for
Acute Myeloid Leukemia
Novartis Pharmaceuticals 301
Not applicableStudy completedNCT01360125
What this trial is testing

S0106A, Biomarkers in Samples From Patients With Newly Diagnosed Acute Myeloid Leukemia Treated With Cytarabine-Based Chemotherapy

Who this might be right for
Leukemia
SWOG Cancer Research Network 310
Testing effectiveness (Phase 2)Study completedNCT00070174
What this trial is testing

Gemtuzumab Ozogamicin in Treating Young Patients With Newly Diagnosed Acute Myeloid Leukemia Undergoing Remission Induction and Intensification Therapy

Who this might be right for
Leukemia
Children's Oncology Group 350
Testing effectiveness (Phase 2)Study completedNCT00274807
What this trial is testing

Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia

Who this might be right for
Leukemia
The Cleveland Clinic 40
Not applicableStudy completedNCT04774744
What this trial is testing

Effect of Digital Health Coaching Program on Self-efficacy and Patient Reported Outcomes of Patients With Newly Diagnosed Acute Myeloid Leukemia or Chronic Lymphocytic Leukemia

Who this might be right for
Acute Myeloid LeukemiaChronic Lymphocytic Leukemia
M.D. Anderson Cancer Center 157
Testing effectiveness (Phase 2)Looking for participantsNCT05904106
What this trial is testing

Venetoclax Plus Azacitidine Versus Intensive Chemotherapy for Fit Patients With Newly Diagnosed NPM1 Mutated AML

Who this might be right for
Acute Myeloid Leukemia
Technische Universität Dresden 146
Early research (Phase 1)Study completedNCT01390337
What this trial is testing

Assess AC220 Given in Combination With Induction and Consolidation Therapy in Newly Diagnosed Acute Myeloid Leukemia (AML)

Who this might be right for
Leukemia, Myeloid, Acute
Daiichi Sankyo 19
Early research (Phase 1)Study completedNCT02834390
What this trial is testing

Study of Quizartinib in Japanese Patients With Newly Diagnosed Acute Myeloid Leukemia (AML)

Who this might be right for
Acute Myeloid Leukemia
Daiichi Sankyo Co., Ltd. 7
Large-scale testing (Phase 3)Study completedNCT00931138
What this trial is testing

Treatment of Acute Myeloid Leukemia (AML) in Adults 50 to 70 Years, Study of Two Anthracyclines and the Interest of Maintenance Treatment With Interleukin 2

Who this might be right for
Acute Myeloid Leukemia
Acute Leukemia French Association 420
Early research (Phase 1)WithdrawnNCT02826642
What this trial is testing

A Dose Finding Study of IDH305 With Standard of Care in IDH1 Mutant Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia (AML)
Novartis Pharmaceuticals
Testing effectiveness (Phase 2)UnknownNCT03135054
What this trial is testing

Combination of Quizartinib and Omacetaxine Mepesuccinate for AML Carrying FLT3-ITD

Who this might be right for
AMLFLT3-ITD Mutation
The University of Hong Kong 40
Large-scale testing (Phase 3)Not Yet RecruitingNCT07486479
What this trial is testing

Venetoclax, Azacitidine, and Mitoxantrone Hydrochloride Liposome Versus Idarubicin and Cytarabine in Newly Diagnosed AML

Who this might be right for
Acute Myeloid Leukemia (AML)
The First Affiliated Hospital of Soochow University 204
Testing effectiveness (Phase 2)Looking for participantsNCT03214562
What this trial is testing

Venetoclax With Combination Chemotherapy in Treating Patients With Newly Diagnosed or Relapsed or Refractory Acute Myeloid Leukemia

Who this might be right for
High Risk Myelodysplastic SyndromeRecurrent Acute Myeloid LeukemiaRefractory Acute Myeloid Leukemia
M.D. Anderson Cancer Center 116
Early research (Phase 1)Active Not RecruitingNCT04953780
What this trial is testing

2157GCCC:Phase 1 of Calaspargase Pegol-mknl W/ Cytarabine and Idarubicin in Newly Dx AML

Who this might be right for
Acute Myeloid Leukemia
West Virginia University 6
Testing effectiveness (Phase 2)Looking for participantsNCT07078591
What this trial is testing

Venetoclax-containing Therapy Combined With Microtransplant for Newly Diagnosed AML

Who this might be right for
Acute Myeloid Leukemia
Beijing 302 Hospital 50
Load More Results